Legend Biotech (LEGN) Enterprise Value (2019 - 2025)
Legend Biotech (LEGN) posted Enterprise Value of -$901.9 million for Q4 2025, down 223.39% on a QoQ basis from -$278.9 million in Q3 2025, and down 214.58% year-over-year from $787.1 million in Q4 2024.
Legend Biotech (LEGN) Enterprise Value (2019 - 2025) Analysis & Trends
Legend Biotech's Enterprise Value history runs 7 years deep, the most recent figure standing at -$901.9 million for Q4 2025.
- Quarterly Enterprise Value fell 214.58% year-over-year to -$901.9 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$901.9 million (down 214.58% YoY) and the FY2025 annual result came in at -$901.9 million, down 214.58% from the prior year.
- Enterprise Value was -$901.9 million for Q4 2025 at Legend Biotech, down from -$278.9 million in the prior quarter.
- Across five years, Enterprise Value topped out at -$50.7 million in Q2 2024 and bottomed at -$1.4 billion in Q2 2023.
- A 5-year average of -$621.8 million and a median of -$465.0 million in 2021 frame the typical range for Enterprise Value.
- Annual changes were most pronounced in 2024 — Enterprise Value jumped 96.43% — and 2025, when it slumped 425.88%.
- Legend Biotech's Enterprise Value stood at -$688.9 million in 2021, then slumped by 41.03% to -$971.6 million in 2022, then tumbled by 31.57% to -$1.3 billion in 2023, then soared by 77.57% to -$286.7 million in 2024, then slumped by 214.58% to -$901.9 million in 2025.
- Business Quant data shows LEGN's Enterprise Value at -$901.9 million in Q4 2025, -$278.9 million in Q3 2025, and -$266.6 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -283.54 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | -61.40 Mn |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.83 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | -4.79 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | -7.25 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -8.75 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -1.91 Bn |
| 10 | Legend Biotech | 8.26 Bn | 7.36 Bn | - | -901.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -901.90 Mn |
| Sep 30, 2025 | -278.89 Mn |
| Jun 30, 2025 | -266.59 Mn |
| Mar 31, 2025 | -441.70 Mn |
| Dec 31, 2024 | -286.70 Mn |
| Sep 30, 2024 | -309.48 Mn |
| Jun 30, 2024 | -50.69 Mn |
| Mar 31, 2024 | -1.05 Bn |
| Dec 31, 2023 | -1.28 Bn |
| Sep 30, 2023 | -1.15 Bn |
| Jun 30, 2023 | -1.42 Bn |
| Mar 31, 2023 | -845.76 Mn |
| Dec 31, 2022 | -971.63 Mn |
| Sep 30, 2022 | -652.73 Mn |
| Jun 30, 2022 | -279.78 Mn |
| Mar 31, 2022 | -277.79 Mn |
| Dec 31, 2021 | -688.94 Mn |
| Sep 30, 2021 | -388.37 Mn |
| Jun 30, 2021 | -488.22 Mn |
| Mar 31, 2021 | -412.30 Mn |